In keeping with its open platform strategy, Incyte Genomics Inc. licensed its portfolio of proprietary gene sequences, including the LifeSeq Gold and ZooSeq databases, to Motorola Inc. 's BioChip Systems unit, which will use the information to make bioarrays used for gene expression, SNP scoring, genotyping, and protein expression. It becomes the first biochip manufacturer to take a license from Incyte, which will get royalties on array sales.
Motorola BioChip Systems, which only began beta testing its products earlier this year, is positioning itself to become a low-cost,...
Welcome to In Vivo
Create an account to read this article
Already a subscriber?